The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York The FDA just announced that they're taking steps to lift restrictions on 12 peptides including BPC 157 and TB 500 making them accessible through compounding pharmacies again. This is a HUGE step Peptides Lack Reliable Safety Information, Watchdog Warns FDA to weigh easing limits on unproven peptides An FDA Reversal on Peptides Could Open the Market to Unsafe Drugs ProPublica FDA moves toward easing restrictions on certain peptides BioPharma Dive